Cargando…
ONECUT2 as a new therapeutic target in androgen receptor-indifferent prostate cancer
Autores principales: | Freeman, Michael R., Rotinen, Mirja, You, Sungyong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798022/ https://www.ncbi.nlm.nih.gov/pubmed/35117025 http://dx.doi.org/10.21037/tcr.2019.10.15 |
Ejemplares similares
-
ONECUT2 Activates Diverse Resistance Drivers of Androgen Receptor-Independent Heterogeneity in Prostate Cancer
por: Qian, Chen, et al.
Publicado: (2023) -
Clinical Considerations for the Management of Androgen Indifferent Prostate Cancer
por: Berchuck, Jacob E., et al.
Publicado: (2021) -
Targeting Key Players of Neuroendocrine Differentiation in Prostate Cancer
por: Zamora, Irene, et al.
Publicado: (2023) -
Drivers of AR indifferent anti-androgen resistance in prostate cancer cells
por: Handle, Florian, et al.
Publicado: (2019) -
Autonomous action and cooperativity between the ONECUT2 transcription factor and its 3′ untranslated region
por: Steadman, Kenneth, et al.
Publicado: (2023)